Stents Drug Eluting

electronic stent, bioresorbable electronic stent

With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic stents” to monitor a treated lesion site inside a patient’s artery. A Korean-led team re...

BEST trial, ACC.15,

Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study...

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to have a heart attack than those whose treatment fol...

bioresorbable stents, dissolving stents

A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC) meetings is that bioresorbable stents will eventually replace conventional metallic stents...

Xposition S, Stentys, SETUP trial, results, EuroPCR, EuroIntervention
Stentys announced that the findings of the first Xposition clinical experience, as part of the SETUP trial, were presented at the EuroPCR conference in May....
electronic stents, bioresorbable electronic stent, BES
With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic...
OrbusNeich, Combo, EPC, HARMONEE study, U.S.
OrbusNeich has announced that the first U.S. patient has been enrolled in the HARMONEE (Harmonized Assessment by Randomized, Multi-center Study of OrbusNEich's...
Boston Scientific, Synergy, EVOLVE I, EVOLVE II, EuroPCR 2015, results
Boston Scientific reported positive, long-term data from the EVOLVE Trial of the Synergy everolimus-eluting bioabsorbable polymer platinum chromium coronary...
The Abbott family of Xience everolimus-eluting coronary stents—including the Xience V, Xience nano, Xience Prime, Xience Xpedition, and
The 34 and 38 mm lengths of the Medtronic Resolute Integrity drug-eluting stent in diameters of 3, 3.5 and 4 mm with an indication for...
Cook Medical’s Zilver PTX drug-eluting peripheral stent is the first device of its kind on several fronts to go before FDA review...

Articles

electronic stents, bioresorbable electronic stent, BES
With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic...
BEST Trial
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared...
Medtronic, Drug Filled Stent, clinical trial, ACC
Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent (DFS) at the 64th Annual Scientific Session of the American College of...
bioresorbable stents
Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely expected to overtake metallic stents in the...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
5 days 8 hours ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
3 weeks 1 day ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
6 weeks 1 day ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...